Cubist Systematic Strategies’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-426
Closed -$20K 2424
2018
Q3
$20K Sell
426
-674
-61% -$32.6K ﹤0.01% 1786
2018
Q2
$53K Sell
1,100
-8,966
-89% -$429K ﹤0.01% 1637
2018
Q1
$436K Buy
10,066
+3,448
+52% +$155K 0.03% 898
2017
Q4
$263K Sell
6,618
-4,864
-42% -$203K 0.01% 1346
2017
Q3
$498K Sell
11,482
-1,487
-11% -$67.9K 0.03% 830
2017
Q2
$621K Buy
12,969
+3,349
+35% +$156K 0.04% 643
2017
Q1
$395K Buy
+9,620
New +$402K 0.03% 764
2016
Q4
Sell
-6,157
Closed -$331K 1993
2016
Q3
$331K Buy
+6,157
New +$286K 0.02% 949
2016
Q2
Sell
-7,937
Closed -$401K 1986
2016
Q1
$401K Sell
7,937
-16,480
-67% -$793K 0.02% 847
2015
Q4
$1.55M Buy
24,417
+3,020
+14% +$206K 0.09% 301
2015
Q3
$1.4M Buy
21,397
+8,913
+71% +$591K 0.07% 404
2015
Q2
$845K Sell
12,484
-9,831
-44% -$542K 0.04% 666
2015
Q1
$953K Buy
22,315
+9,172
+70% +$408K 0.05% 601
2014
Q4
$650K Sell
13,143
-2,214
-14% -$88.6K 0.04% 733
2014
Q3
$441K Buy
+15,357
New +$417K 0.03% 903

Other funds holding IMPV

Cubist Systematic Strategies's IMPV Position: Q4 2018 in Review

Cubist Systematic Strategies sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 426 shares — an estimated $20K sold.

Cubist Systematic Strategies first reported a position in IMPV in Q3 2014 and held it in 15 quarters. The position peaked at $1.55M in Q4 2015. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.

  • Cubist Systematic Strategies reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
  • Cubist Systematic Strategies sold 426 Imperva, Inc. shares in Q4 2018, an estimated $20K.
  • Cubist Systematic Strategies first reported a position in Imperva, Inc. in Q3 2014 and held it in 15 quarters.
  • Cubist Systematic Strategies's Imperva, Inc. position peaked at $1.55M in Q4 2015.
  • 162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.

Based on Cubist Systematic Strategies's 13F filing for Q4 2018, filed 14 Feb 2019.